|Selected news articles which highlight important policy issues.||
News: Weekly Archives
News for the week of 03-18-2005
Roche, Glaxo await OK for easier osteoporosis drug.
Reuters reports on a new “once-monthly osteoporosis pill [that] could be good news for sufferers of the brittle bone disease.” The FDA is currently slated to rule on Roche/Glaxo’s application for the drug, called Boniva, on March 26, in just a few days.
Boniva may turn out to be a more convenient treatment for patients, since current treatments “have to be taken in the morning on an empty stomach and patients must remain upright for 30 to 45 minutes.”
Other companies are working on drugs that would require even less frequent dosing, from every three months to perhaps only once a year.
“Osteoporosis, which causes a loss in bone mass, is most common in older women after the menopause when levels of the female hormone estrogen drop. It occurs in about one in three elderly women and one in 12 older men.”
|home spotlight commentary research events news about contact links archives|